UPMC and University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.
The paper appeared in EBioMedicine, which is published by The Lancet, and is the first study to be published after critique from fellow scientists at outside institutions that describes a candidate vaccine for COVID-19. The researchers were able to act quickly because they had already laid the groundwork during earlier coronavirus epidemics.
Watch the press conference, which features UPMC and Pitt School of Medicine scientists speaking on the vaccine and the status of the COVID-19 pandemic in western Pennsylvania and beyond.
UPMC will be regularly updating the community on this developing situation. Follow UPMC News for updates.
